Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 West Launches B.safe Syringe System | Contract Pharma

What are you searching for?

Sign in
Breaking News

West Launches B.safe Syringe System

Completes product development and first phase of commercial scale-up

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

West has introduced its B.safe syringe safety system. The company acquired the IP and rights to the system in 2011 and has completed the product development and first phase of commercial scale-up at its manufacturing center in France. Scale-up to high-volume manufacturing is expected in 1H13.
 
The system is designed to help protect against needlestick injury when using a prefilled syringe. West’s prefilled syringe portfolio also includes the NovaGuard passive needle system for Luer Lock syringes and the eris system.
 
“We are delighted to reach this significant milestone and be in a position to offer our customers a globally available safety system, leveraging our established expertise around prefilled syringes and needle safety,” said Glenn Thorpe, vice president, Strategic Market Development, Syringe Systems. “With the completion of the steps necessary to offer this system commercially, we are in position to meet growing market demand in this area, and are pleased to have already signed our first commercial agreement and commenced shipments.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters